압박 의류 및 스타킹 시장 : 제품 유형, 소재, 성별, 용도, 최종 용도, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Compression Garments & Stockings Market is projected to grow by USD 5.22 billion at a CAGR of 5.42% by 2032.

Compression garments and stockings are medical and performance textiles designed to apply controlled pressure to the limbs, supporting venous return, edema management, post-surgical recovery, lymphedema care, and thrombosis risk reduction. Demand is supported by well-documented demographic and clinical factors, including aging populations, chronic venous disease, diabetes-related vascular complications, obesity, pregnancy, prolonged standing occupations, and sedentary travel.

The category spans graduated compression stockings, sleeves, wraps, bandages, and specialty garments across medical, sports, maternity, and wellness channels. For SEO and commercial planning, the most relevant growth themes include medical compression stockings, graduated compression therapy, venous insufficiency treatment, lymphedema compression garments, diabetic-friendly compression wear, and postoperative compression apparel.

Transformative Shifts Reshaping the Competitive Landscape

The market is shifting from one-size-fits-most hosiery toward clinically validated, patient-specific compression solutions. Manufacturers are investing in breathable yarns, seamless knitting, moisture management, antimicrobial finishes where substantiated, and easier donning features because adherence is a known challenge in compression therapy. Product differentiation increasingly depends on comfort, fit accuracy, durability, skin safety, and evidence-based pressure performance.

Distribution is also changing. Pharmacies, durable medical equipment providers, vascular clinics, wound care centers, orthopedic practices, maternity channels, and eCommerce platforms now influence patient access. Regulatory scrutiny remains important because many medical compression products are treated as medical devices in key markets, requiring quality systems, labeling accuracy, biocompatibility considerations, and substantiated therapeutic claims.

Cumulative Impact of Artificial Intelligence on Compression Solutions

Artificial intelligence is becoming a cumulative enabler rather than a standalone product feature. In compression garments, AI is most valuable in digital sizing, demand planning, inventory optimization, claims review, customer support, and personalization workflows. Computer vision and guided measurement tools can reduce sizing errors, while predictive analytics can help suppliers align stock with seasonality, procedure volumes, regional disease burden, and channel-level purchasing behavior.

AI also supports clinical workflow when combined with secure patient data governance. Decision-support tools can help flag adherence risks, identify fit-related complaints, or recommend follow-up based on reported symptoms, but medical decisions still require qualified healthcare oversight. The strongest AI use cases are those that improve fit, access, compliance, education, and supply chain reliability without overstating therapeutic outcomes.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is gaining importance as China, India, Japan, South Korea, and Australia combine large patient pools with expanding healthcare access, rising diabetes and obesity-related vascular risks, active aging populations, and strong textile manufacturing capabilities. North America remains a high-value regional environment because the United States and Canada have established vascular care pathways, wound care infrastructure, reimbursement and prescribing practices for select medical uses, strong sports recovery demand, and mature direct-to-consumer and pharmacy channels.

Europe benefits from aging demographics, clinical acceptance of graduated compression therapy, and regulated medical device standards that support product safety and documentation across major markets. Latin America shows opportunity through Brazil and Mexico as private healthcare networks, pharmacy chains, diabetes care programs, and urban specialty clinics expand access to compression stockings and postoperative garments. The Middle East is supported by premium healthcare investment in Gulf states, high rates of metabolic disease, and demand for hospital-based and wellness-oriented products, while Africa remains earlier-stage but increasingly relevant where urbanization, diabetes prevalence, surgical care access, and maternal health needs are rising.

Key Group Insights for ASEAN, GCC, European Union, BRICS, G7, and NATO Markets

ASEAN markets are shaped by expanding retail pharmacy access, medical tourism, rising middle-class healthcare spending, and increasing awareness of venous and diabetic complications. The GCC is driven by high healthcare expenditure, hospital modernization, chronic disease management priorities, and demand for premium medical and wellness products. The European Union emphasizes regulatory conformity, clinical documentation, post-market surveillance, product safety, and labeling discipline under a harmonized medical device environment.

BRICS countries combine demographic scale, manufacturing depth, rising chronic disease burdens, and expanding healthcare infrastructure, creating opportunities for value-oriented, locally adapted compression products. G7 markets remain innovation-led, with stronger adoption of digital fitting, premium materials, evidence-based compression classes, and clinically differentiated products. NATO countries overlap with many high-income healthcare systems where occupational health, military readiness, rehabilitation, travel-related thrombosis prevention guidance, and procurement standards can influence institutional and clinical demand.

Key Country Insights Across Major Compression Garments and Stockings Markets

The United States leads in product variety, vascular specialty care, wound care, sports recovery, postoperative compression, and eCommerce adoption, while Canada emphasizes regulated access and clinical use through pharmacy, hospital, and healthcare professional channels. Mexico and Brazil are important Latin American markets due to large urban populations, elevated diabetes burden, expanding private healthcare networks, and growing access to pharmacies and specialty clinics.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through aging populations, established venous disease management, surgical recovery pathways, and clinical use of graduated compression stockings, while Russia remains a scale market with localized distribution and access dynamics. China and India offer substantial volume potential supported by large populations, improving healthcare access, and high chronic disease burdens; Japan and South Korea favor quality, comfort, precision sizing, and technology-enabled solutions; and Australia benefits from strong healthcare access, sports participation, travel activity, and postoperative recovery demand.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically substantiated claims, accurate compression classification, consistent pressure performance, and fit systems that reduce returns and improve patient adherence. Product portfolios should balance medical-grade stockings, easy-donning solutions, diabetic-friendly designs, maternity compression, sports recovery garments, lymphedema sleeves, wraps, and post-surgical compression products.

Commercial teams should strengthen partnerships with vascular specialists, wound care providers, pharmacies, orthopedic surgeons, obstetric care providers, rehabilitation centers, and digital health platforms. Manufacturers should invest in sustainable materials, resilient sourcing, quality management, skin-safe designs, and localized assortments. Digital measurement tools, patient education, donning aids, clear contraindication guidance, and laundering instructions can improve outcomes, reduce misuse, and strengthen brand trust.

Research Methodology

This executive summary is developed using a structured research approach that combines secondary research, regulatory review, clinical guideline analysis, product benchmarking, distribution-channel assessment, and demand-driver evaluation. Sources considered include public health agencies, medical device regulations, peer-reviewed clinical literature, reimbursement references, professional clinical guidance, and publicly available manufacturer documentation.

Insights are triangulated across epidemiology, healthcare access, demographic trends, chronic disease burden, surgical recovery needs, distribution channels, material innovation, and digital fitting signals. The methodology avoids unsupported market sizing, market share, and forecasting claims and emphasizes evidence-backed drivers, regional dynamics, and strategic implications relevant to compression garments, compression stockings, graduated compression therapy, venous insufficiency treatment, and lymphedema compression care.

Conclusion

The compression garments and stockings market is advancing from basic support wear to clinically oriented, digitally enabled, and comfort-led therapeutic apparel. Demand is anchored in aging populations, vascular disease management, diabetes-related complications, post-surgical recovery, lymphedema care, maternity support, sports recovery, occupational wellness, and expanding healthcare access across developed and emerging markets.

Success will depend on product evidence, regulatory discipline, patient adherence, accurate fit, pressure consistency, and channel execution. Organizations that combine medical credibility with consumer-friendly design, accessible education, quality manufacturing, and digital convenience are best positioned to build durable competitive advantage in compression garments and medical compression stockings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Compression Garments & Stockings Market, by Product Type

• 7.1. Compression Gloves
• 7.2. Compression Sleeves
• 7.3. Compression Socks
• 7.4. Compression Stockings
• 7.5. Compression Tights

8. Compression Garments & Stockings Market, by Material

• 8.1. Natural
  • 8.1.1. Cotton
  • 8.1.2. Rubber
• 8.2. Synthetic
  • 8.2.1. Nylon
  • 8.2.2. Spandex

9. Compression Garments & Stockings Market, by Gender

• 9.1. Female
• 9.2. Male
• 9.3. Unisex

10. Compression Garments & Stockings Market, by Application

• 10.1. Deep Vein Thrombosis Prevention
• 10.2. Lymphedema Management
• 10.3. Postoperative Recovery
• 10.4. Pregnancy Support
• 10.5. Sports Performance
• 10.6. Varicose Vein Treatment

11. Compression Garments & Stockings Market, by End Use

• 11.1. Industrial
• 11.2. Medical
• 11.3. Sports

12. Compression Garments & Stockings Market, by Distribution Channel

• 12.1. Hospital & Clinic
• 12.2. Online Retail
• 12.3. Pharmacy & Drug Store
• 12.4. Specialty Store
• 12.5. Sports Outlet

13. Compression Garments & Stockings Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Compression Garments & Stockings Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Compression Garments & Stockings Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. 3M Company
• 17.2. AMERX Health Care Corp. by Procyon Corporation
• 17.3. Bio Compression Systems, Inc.
• 17.4. Bodyment
• 17.5. Calze G.T. S.r.l.
• 17.6. Cardinal Health, Inc.
• 17.7. ContourMD
• 17.8. Dermawear by CPS Shapers Limited
• 17.9. DirectDermaCare
• 17.10. Essity AB
• 17.11. FeelWell
• 17.12. Julius Zorn GmbH
• 17.13. Kinex Medical Company, LLC
• 17.14. Lipoelastic
• 17.15. Lohmann & Rauscher GmbH & Co. KG
• 17.16. LYCRA Company
• 17.17. Lymphedema Products, LLC
• 17.18. MACOM Enterprises Ltd.
• 17.19. medi GmbH & Co. KG
• 17.20. Nouvelle Inc.
• 17.21. Paul Hartmann AG
• 17.22. Rainey Recovery Wear
• 17.23. Rehan International Co., Ltd.
• 17.24. Sanyleg SRL
• 17.25. SIGVARIS Group
• 17.26. The Marena Group, LLC
• 17.27. Tommie Copper, Inc.
• 17.28. Wear Ease